VisMederi Pharma is part of the larger VisMederi Group, a group with expertise in the evaluation of vaccine immunogenicity, with focus on influenza and SARS-CoV-2 serology. VisMederi headquarters are located in Monteriggioni, Siena, Italy.
VisMederi Pharma aims at contributing to the improvement of people’s health and wellbeing through the discovery, development and production of vaccines, therapeutics and diagnostics. VisMederi Pharma’s mission is to protect people from serious infectious diseases, including those caused by emerging pathogens. VisMederi Pharma operates in the biological field, with focus on vaccines and biologicals following an established secular tradition in the Sienese area. VisMederi Pharma retains vaccine and biotechnological expertise and benefits of extensive professional experience in this field by management teams.